Group | Total | Survival of 5 years or more | Survival of less than 5 years | P a) |
---|---|---|---|---|
N | 49 | 21 | 28 | Â |
1) Demographic/clinicopathologic | Â | Â | Â | Â |
   Age, yr | 64.5 ± 7.4 (48 -78) b) | 67.3 ± 5.8 (60 -78) | 62.4 ± 7.9 (48 -76) | 0.020 |
   Height, cm | 163.5 ± 6.6 (150-180) | 161.9 ± 6.1 (150-171) | 164.8 ± 6.8 (152-180) | 0.125 |
   Weight, kg | 56.1 ± 9.6 (33-79) | 59.8 ± 9.5 (40-74) | 53.3 ± 8.9 (33-79) | 0.019 |
   Male/Female | 46/3 | 20/1 | 26/2 | 1.000 |
   Performance status, 0/1/2/unknown | 24/20/4/1 | 11/7/2/1 | 13/13/2/0 | 0.579 |
   Differentiation, well/moderate/poor/unknown | 7/28/8/6 | 4/11/3/3 | 3/17/5/3 | 0.817 |
   T1/T2/T3/T4 | 16/6/15/12 | 10/2/7/2 | 6/4/8/10 | 0.099 |
   N0/N1 | 22/27 | 13/8 | 9/19 | 0.048 |
   M0/M1a c) | 41/8 | 20/1 | 21/7 | 0.115 |
   Stage I/II/III/IV | 12/10/19/8 | 7/7/6/1 | 5/3/13/7 | 0.048 |
2) Clinical outcome | Â | Â | Â | Â |
   Complete response | 23 (46.9%) | 16 (76.2%) | 7 (25.0%) | 0.0005 |
   Grade 3/4 Leucopenia | 21(42.9%) | 9 (42.9%) | 12 (42.9%) | 1.000 |
   Grade 3/4 Stomatitis | 7 (14.3%) | 4 (19.0%) | 3 (10.7%) | 0.443 |
   Grade 3/4 Cheilitis | 8 (16.3%) | 4 (19.0%) | 4 (14.3%) | 0.710 |